Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 5 | Cell & Bioscience

Fig. 5

From: Microglia and macrophage metabolism: a regulator of cerebral gliomas

Fig. 5

Therapeutic strategies targeting metabolism between GAMs and Gliomas. a Therapeutic strategies targeting arginine metabolism. ADI-PEG20, an arginine consumer, decomposes arginine in the TME, and induces upregulation of NOS2 expression and downregulation of Arg1 to promote M1-like polarization. In addition, ADI-PEG20 enhances the phagocytic ability of GAMs, and promotes the M1-like factors secretion. b Therapeutic strategies targeting tryptophan metabolism. Endogenous tryptophan metabolites and the NAD+ precursor quinolinic acid render gliomas resistant to radiotherapy and chemotherapy. Alkylating agents may alleviate therapeutic resistance by depleting intracellular NAD+. c Therapeutic strategies targeting glucose metabolism. HOE-642, an inhibitor of NHE1, significantly promotes infiltration of GAMs and T cells, upregulates mitochondrial OXPHOS pathway genes, enhances mitochondrial activity in immune cells, and diminishes glycolysis in GAMs and T cells. d Therapeutic strategies using microglia-derived sEV. Microglia-derived sEV carrying miR-124 alters the metabolism of glioma cells and reduces the release of lactate, NO and glutamate. In addition, sEV increases the expression of Glu transporter Glt-1 in astrocytes. e Therapeutic strategies targeting lipid metabolism. NR4A2 or SQLE inhibitors suppress tumor growth and reversed CD8+ T cell exhaustion. NR-encased hydrogel system and oncolytic adenovirus loaded with ApoA1 activate anti-tumor immunity through targeting the disordered cholesterol metabolism in GBMs. NOS2, nitric oxide synthase 2; NO, nitric oxide; Arg1, arginase 1; Trp, tryptophan; TDO, tryptophan-2,3-dioxygenase; 3-HA, 3-hydroxyanthranilic acid; 3-HAO, 3-hydroxy-anthranilic acid oxygenase; QPRT, quinolinic acid phosphoribosyl transferase; NHE1, Na/H exchanger isomer 1; OXPHOS, oxidative phosphorylation; sEV, small extracellular vesicles; Glt-1, glutamate transporter type 1; NR4A2, nuclear receptor subfamily 4 group A member 2; SQLE, squalene monooxygenase; ApoA1, apolipoprotein A1; DHCR7, 7-dehydrocholesterol reductase

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us